âThe failure to submit or complete MDS 3.0 discharge assessment records leads to inaccurate MDS 3.0 Quality Measures (QMs) data, potentially affecting the resident, the facility's payment and facility liabilities,â the memo states.
For the Consumer. Applies to sucralfate: oral suspension, oral tablet. In addition to its needed effects, some unwanted effects may be caused by sucralfate (the active ingredient contained in Carafate). In the event that any of these side effects do occur, they may require medical attention.
Carafate is used for: Short-term (up to 8 weeks) treatment of certain intestinal ulcers. It is also used in patients that have had certain intestinal ulcers to prevent further development of more ulcers. It may also be used for other conditions as determined by your doctor. Carafate is a gastric protective agent.